Haemonetics Corporation
HAE
Key stats
- Open
- 120.78
- Day high
- 124.00
- Day low
- 119.45
- Previous close
- 120.54
- Volume
- 597.6K
- VWAP
- 122.19
- 52-week high
- 132.00
- 52-week low
- 51.00
- Market cap
- 5.49B
- Shares out
- 45.54M
- Employees
- 3,009
- Listed
- 1991
About Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · BOSTON, MA · haemonetics.com
Options · expiring Nov 20
Nov 12, 3:59 PM ET- Call open interest
- 2.4K
- Put open interest
- 1.8K
- Put/call
- 0.76
- At-the-money IV
- 37.9%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 145 call | 0.89 | Nov 5, 3:34 PM | 40 | 43 | 80.6% |
| 125 put | 6.70 | Nov 4, 2:57 PM | 16 | 53 | 47.7% |
| 130 put | 9.90 | Nov 4, 2:56 PM | 9 | 9 | 49.6% |
| 125 call | 2.00 | Nov 12, 12:27 PM | 6 | 84 | 37.9% |
| 105 call | 18.30 | Oct 9, 3:01 PM | 5 | 110 | 0.1% |
| 115 call | 2.20 | Nov 10, 9:30 AM | 4 | 326 | 29.6% |
Quarterly results
Massive · Nov 5, 2026| Q2 2027 to Sep 26, 2026 | Q1 2027 to Jun 27, 2026 | Q4 2026 to Mar 28, 2026 | Q3 2026 to Dec 27, 2025 | |
|---|---|---|---|---|
| Revenue | $357.76M | $339.38M | $346.35M | $338.97M |
| Gross profit | $210.51M | $202.80M | $198.21M | $202.39M |
| Operating income | $75.12M | $57.46M | −$23.02M | $67.40M |
| Net income | $46.30M | $33.01M | −$20.15M | $44.74M |
| Diluted EPS | 1.00 | 0.72 | -0.43 | 0.95 |
| Operating cash flow | $128.10M | $52.32M | $70.94M | $93.56M |
| Assets | $2.41B | $2.37B | $2.40B | $2.49B |
| Liabilities | $1.51B | $1.53B | $1.60B | $1.58B |
| Equity | $898.50M | $837.10M | $796.32M | $911.45M |
Technicals
Massive · Nov 12, 2026- 50-day average112.91
- 200-day average80.98
- RSI (14 days)58.6
Short interest
Massive · Oct 30, 2026- Oct 30, 20263.60M shares · 6.3 days to cover
- Oct 15, 20263.43M shares · 3.9 days to cover
- Sep 30, 20263.04M shares · 5.3 days to cover
- Sep 15, 20263.42M shares · 5.7 days to cover
Splits
Massive · Dec 3, 2012- Dec 3, 20122-for-1
Related companies
MassiveNews coverage
No stories about Haemonetics Corporation right now.